Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Long-term Use of Viltolarsen in Boys With Duchenne Muscular Dystrophy in Clinical Practice (VILT-502)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04687020
Recruitment Status : Recruiting
First Posted : December 29, 2020
Last Update Posted : June 30, 2021
Sponsor:
Information provided by (Responsible Party):
NS Pharma, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : November 2031
Estimated Study Completion Date : November 2031